PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
LBPH vs. UPRO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between LBPH and UPRO is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

LBPH vs. UPRO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Longboard Pharmaceuticals, Inc. (LBPH) and ProShares UltraPro S&P 500 (UPRO). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%AugustSeptemberOctoberNovemberDecember2025
56.36%
10.47%
LBPH
UPRO

Key characteristics

Sharpe Ratio

LBPH:

3.57

UPRO:

1.79

Sortino Ratio

LBPH:

10.37

UPRO:

2.22

Omega Ratio

LBPH:

2.34

UPRO:

1.30

Calmar Ratio

LBPH:

16.18

UPRO:

2.21

Martin Ratio

LBPH:

69.96

UPRO:

10.56

Ulcer Index

LBPH:

16.73%

UPRO:

6.37%

Daily Std Dev

LBPH:

327.67%

UPRO:

37.64%

Max Drawdown

LBPH:

-82.95%

UPRO:

-76.82%

Current Drawdown

LBPH:

0.00%

UPRO:

-9.44%

Returns By Period


LBPH

YTD

0.00%

1M

0.00%

6M

56.36%

1Y

164.70%

5Y*

N/A

10Y*

N/A

UPRO

YTD

1.35%

1M

-7.07%

6M

10.47%

1Y

65.21%

5Y*

20.66%

10Y*

24.49%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

LBPH vs. UPRO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LBPH
The Risk-Adjusted Performance Rank of LBPH is 9999
Overall Rank
The Sharpe Ratio Rank of LBPH is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of LBPH is 100100
Sortino Ratio Rank
The Omega Ratio Rank of LBPH is 9999
Omega Ratio Rank
The Calmar Ratio Rank of LBPH is 100100
Calmar Ratio Rank
The Martin Ratio Rank of LBPH is 100100
Martin Ratio Rank

UPRO
The Risk-Adjusted Performance Rank of UPRO is 7373
Overall Rank
The Sharpe Ratio Rank of UPRO is 7575
Sharpe Ratio Rank
The Sortino Ratio Rank of UPRO is 6969
Sortino Ratio Rank
The Omega Ratio Rank of UPRO is 7171
Omega Ratio Rank
The Calmar Ratio Rank of UPRO is 7070
Calmar Ratio Rank
The Martin Ratio Rank of UPRO is 7777
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

LBPH vs. UPRO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Longboard Pharmaceuticals, Inc. (LBPH) and ProShares UltraPro S&P 500 (UPRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for LBPH, currently valued at 1.65, compared to the broader market-4.00-2.000.002.001.651.79
The chart of Sortino ratio for LBPH, currently valued at 2.81, compared to the broader market-4.00-2.000.002.004.002.812.22
The chart of Omega ratio for LBPH, currently valued at 1.37, compared to the broader market0.501.001.502.001.371.30
The chart of Calmar ratio for LBPH, currently valued at 4.04, compared to the broader market0.002.004.006.004.042.21
The chart of Martin ratio for LBPH, currently valued at 8.43, compared to the broader market-10.000.0010.0020.008.4310.56
LBPH
UPRO

The current LBPH Sharpe Ratio is 3.57, which is higher than the UPRO Sharpe Ratio of 1.79. The chart below compares the historical Sharpe Ratios of LBPH and UPRO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00AugustSeptemberOctoberNovemberDecember2025
1.65
1.79
LBPH
UPRO

Dividends

LBPH vs. UPRO - Dividend Comparison

LBPH has not paid dividends to shareholders, while UPRO's dividend yield for the trailing twelve months is around 0.91%.


TTM20242023202220212020201920182017201620152014
LBPH
Longboard Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
UPRO
ProShares UltraPro S&P 500
0.91%0.93%0.74%0.52%0.06%0.11%0.41%0.63%0.00%0.12%0.34%0.22%

Drawdowns

LBPH vs. UPRO - Drawdown Comparison

The maximum LBPH drawdown since its inception was -82.95%, which is greater than UPRO's maximum drawdown of -76.82%. Use the drawdown chart below to compare losses from any high point for LBPH and UPRO. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember20250
-9.44%
LBPH
UPRO

Volatility

LBPH vs. UPRO - Volatility Comparison

The current volatility for Longboard Pharmaceuticals, Inc. (LBPH) is 0.00%, while ProShares UltraPro S&P 500 (UPRO) has a volatility of 13.48%. This indicates that LBPH experiences smaller price fluctuations and is considered to be less risky than UPRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%AugustSeptemberOctoberNovemberDecember20250
13.48%
LBPH
UPRO
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab